Trane Technologies plc (I1RP34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 61.50 |
|---|---|
| 52-week range | 50.01 – 64.91 |
| Return, 1 month / 3 months | +4.0% / +0.3% |
| Return, 1 year / 3 years | +7.1% / +172.4% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 28.0% |
| Worst drawdown (1 year) | -14.5% |
| Average daily value traded | 0.14M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Trane Technologies plc is an industrial company focused on heating, ventilation, air conditioning and refrigeration. It provides climate-control equipment and services for buildings and homes, and transport refrigeration systems for moving food and other temperature-sensitive goods. Its customers include commercial building owners, contractors, and food and pharmaceutical logistics operators. The company is incorporated in Ireland and runs its main operations from the United States, serving markets around the world.
Trane Technologies plc is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code I1RP34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Trane Technologies plc (I1RP34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 61.50 on 27 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 318 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.1% and over the last three months it rose 0.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.1% | ||
| From 52-week high | -5.3% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.3% | ||
| 6-month return | 6.7% | ||
| 12-month return, skipping the last month | 3.0% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.5% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.14M BRL | ||
| Zero-volume days | 23.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +6.7% |
|---|---|
| 1 month | +4.0% |
| 3 months | +0.3% |
| 6 months | +6.7% |
| 1 year | +7.1% |
| 3 years | +172.4% |
| 5 years | +158.6% |
Signals
| 50-day / 200-day average | 58.38 / 57.94 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | EUR 0.1025 |
| 3 Jun 2026 | EUR 2.0454 |
| 5 Mar 2026 | EUR 2.0318 |
| 4 Dec 2025 | EUR 1.9164 |
| 4 Sep 2025 | EUR 1.8754 |
| 5 Jun 2025 | EUR 1.9214 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.